JAKARTA - PT Diagnos Laboratories Utama Tbk (DGNS), the operator of the Diagnos clinic, has invested US$ 300,000 in Asa Ren Pte Ltd Singapore. For information, Asa Ren is a start-up company in the field of bioinformatics.

In the disclosure published on Wednesday (1/2), Mesha Rizal Sini, President Director of PT Diagnos Laboratory Utama Tbk (DGNS) said that the company included 58,656 shares of the A1 series. With an exchange rate of IDR 15,020 per share, the investment value is equivalent to IDR 4.50 billion.

According to him, the company can develop genetic testing services by investing in Asa Ren. The startup is considered to be focused on studying gene studies in human DNA. The study of related studies can provide relevant insights about lifestyle and human health. (LK/LM)